CAGGIANO, Anthony,GANGULY, Anindita,IACI, Jennifer,PARRY, Tom
申请号：
HK18115772
公开号：
HK1256637A1
申请日:
2018.12.10
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
